Patents by Inventor Dong HO BAK

Dong HO BAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372503
    Abstract: The present application relates to a functional polypeptide variant-lasting protein conjugate. The functional polypeptide variant-lasting protein conjugate of the present application is prepared by an inverse electron-demand Diels-Alder (IEDDA) reaction using a tetrazine group. In addition, the present application provides a functional polypeptide variant including a non-natural amino acid. The non-natural amino acid included in the functional polypeptide of the present application is characterized by including a tetrazine group or triazine group.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 23, 2023
    Inventors: Jeong Haeng CHO, Sun Oh SHIN, Hyun Woo KIM, Hyeongseok KIM, Dong Ho BAK, Su Jung JEON, Inchan KWON, Byungseop YANG
  • Publication number: 20230211002
    Abstract: The present specification discloses a urate oxidase-albumin conjugate, a preparation method thereof, a urate oxidase variant contained in the urate oxidase-albumin conjugate, and a preparation method thereof. The urate oxidase-albumin conjugate is characterized in that three or more albumins are conjugated to the urate oxidase variant through a linker, thereby improving half-life and reducing immunogenicity. In addition, the urate oxidase-albumin conjugate can be used to prevent or treat various diseases, disorders and/or indications caused by uric acid.
    Type: Application
    Filed: September 24, 2021
    Publication date: July 6, 2023
    Inventors: Jeong Haeng Cho, Sun Oh Shin, Hyun Woo Kim, Hyeongseok Kim, Dong Ho Bak, Inchan Kwon
  • Publication number: 20230149517
    Abstract: The present specification discloses a urate oxidase-albumin conjugate, a preparation method thereof, a urate oxidase variant contained in the urate oxidase-albumin conjugate, and a preparation method thereof. The urate oxidase-albumin conjugate is characterized in that three or more albumins are conjugated to the urate oxidase variant through a linker, thereby improving half-life and reducing immunogenicity. In addition, the urate oxidase-albumin conjugate can be used to prevent or treat various diseases, disorders and/or indications caused by uric acid.
    Type: Application
    Filed: October 28, 2022
    Publication date: May 18, 2023
    Inventors: Jeong Haeng CHO, Sun Oh Shin, Hyun Woo Kim, Hyeongseok Kim, Dong Ho Bak, Inchan Kwon
  • Publication number: 20200384082
    Abstract: The present invention provides a cosmetic composition and a pharmaceutical composition comprising secretions of natural killer cells, which are excellent in increasing various factors related to improvement of atopic dermatitis, hair loss, wounds or skin wrinkles, and in enhancing an expression level, and thereby having excellent alleviation effects on the symptoms.
    Type: Application
    Filed: December 13, 2018
    Publication date: December 10, 2020
    Applicant: Green Cross Wellbeing Corporation
    Inventors: Chang Taek OH, Min Ju LIM, Jeom Yong KIM, Sun Kyu PARK, Jong Hun LEE, Min Jung JANG, Su AE KIM, Su Hwan LIM, Beom Joon KIM, Dong HO BAK, Tae Rin KWON, Jung Tae NA